Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Joint Corp (JYNT)
NASDAQ:JYNT
Joint (JYNT) Stock Price & Analysis
252 Followers
JYNT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$7.31 - $17.82
Previous Close$13.34
Volume15.29K
Average Volume (3M)68.04K
Market Cap
$200.50M
Enterprise Value$199.11M
Total Cash (Recent Filing)$18.15M
Total Debt (Recent Filing)$16.73M
Price to Earnings (P/E)―
Beta1.41
Next Earnings
Aug 08, 2024EPS Estimate
-$0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.75
Shares Outstanding14,973,910
10 Day Avg. Volume53,752
30 Day Avg. Volume68,043
Standard Deviation0.17
R-Squared0.26
Alpha-0.00678
Financial Highlights & Ratios
Price to Book (P/B)11.48
Price to Sales (P/S)1.77
Price to Cash Flow (P/CF)13.70
P/FCF Ratio19.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.73
Enterprise Value/Gross Profit1.86
Enterprise Value/Ebitda15.33
Forecast
1Y Price Target
$15.38Price Target Upside15.29% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
Joint News
PremiumCompany Announcements
Joint Corp Earnings Presentation and Upcoming Call
Bulls Say, Bears Say
Bulls Say
Capital StrengthAt quarter-end, JYNT had $18.7M in cash and no debt, with no need for additional capital based on the outlook.
Financial PerformanceThe company reported solid Q1 results, with revenue in line and better adjusted EBITDA.
ValuationShares currently trade below 10x next year's EBITDA compared to a peer group of franchise businesses that trade at more than 15x.
Bears Say
Financial ImpactThere is little visibility around the timing and financial impact of the transition plan to convert corporate-owned clinics into franchised units.
Strategic ShiftsSignificant refranchising activities have not yet materialized, and there is a potential for this strategy to slow the pace of new franchise license sales.
UncertaintiesGiven the current uncertainties surrounding the execution and outcomes of these strategic shifts, the absence of conclusive deals, and the slowdown in discretionary consumer spending, a Hold rating is maintained.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
JYNT FAQ
What was Joint Corp’s price range in the past 12 months?
Joint Corp lowest stock price was $7.31 and its highest was $17.82 in the past 12 months.
What is Joint Corp’s market cap?
Currently, no data Available
When is Joint Corp’s upcoming earnings report date?
Joint Corp’s upcoming earnings report date is Aug 08, 2024 which is in 35 days.
How were Joint Corp’s earnings last quarter?
Joint Corp released its earnings results on May 02, 2024. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.005 by $0.055.
Is Joint Corp overvalued?
According to Wall Street analysts Joint Corp’s price is currently Undervalued.
Does Joint Corp pay dividends?
Joint Corp does not currently pay dividends.
What is Joint Corp’s EPS estimate?
Joint Corp’s EPS estimate is -$0.02.
How many shares outstanding does Joint Corp have?
Joint Corp has 14,973,910 shares outstanding.
What happened to Joint Corp’s price movement after its last earnings report?
Joint Corp reported an EPS of $0.06 in its last earnings report, beating expectations of $0.005. Following the earnings report the stock price went up 25.35%.
Which hedge fund is a major shareholder of Joint Corp?
Among the largest hedge funds holding Joint Corp’s share is Bandera Partners. It holds Joint Corp’s shares valued at 51M.
---
Joint Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$15.38 (15.29% Upside)
$15.38 (15.29% Upside)
Blogger Sentiment
Bullish
JYNT Sentiment 100%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 4.9%
Last 30 Days ▼ 4.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-1.03%
12-Months-Change
Fundamentals
Return on Equity
-36.22%
Trailing 12-Months
Asset Growth
-13.99%
Trailing 12-Months
Company Description
Joint Corp
The Joint Corp. (United States) engages in the development, ownership, operation, support and management of chiropractic clinics. It operates through two segments: Corporate Clinics and Franchise Operations. The Corporate Clinics segment comprises of the operating activities of the company owned or managed clinics. The Franchise Operations segment includes the operating activities of the franchise business unit. The Joint was founded by Fred Gerretzen, Charles Barnwell, John Leonesio, Todd Welker, Barbara Holland, Steven P. Colmar, Craig P. Colmar, and Richard Rees on March 10, 2010 and is headquartered in Scottsdale, AZ.
---
JYNT Company Deck
---
JYNT Earnings Call
Q1 2024
0:00 / 0:00
---
JYNT Stock 12 Month Forecast
Average Price Target
$15.38
▲(15.29% Upside)
Technical Analysis
Best Analysts Covering JYNT
1 Year
1 Year Success Rate
10/17 ratings generated profit
1 Year Average Return
+126.06%
reiterated a buy rating 2 months ago
Copying Jeff Van Sinderen's trades and holding each position for 1 Year would result in 58.82% of your transactions generating a profit, with an average return of +126.06% per trade.
---